Connor, Clark & Lunn Investment Management »

Anika Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $432k 46k 9.40
2025-06-30 $455k 43k 10.58
2025-03-31 $517k 34k 15.03
2024-12-31 $682k 41k 16.46
2024-09-30 $1.4M 58k 24.70
2024-06-30 $1.5M 59k 25.33
2024-03-31 $1.5M 60k 25.40
2023-12-31 $1.2M 53k 22.66
2023-09-30 $971k 52k 18.63
2023-06-30 $1.2M 47k 25.98
2023-03-31 $460k 16k 28.72
2015-12-31 $286k 7.5k 38.13
2014-12-31 $415k 8.8k 47.16
2014-09-30 $1.1M 27k 40.97
2014-06-30 $1.5M 31k 49.34
2014-03-31 $2.0M 45k 45.37